Transactions
18
Insider / Kenvue Inc.
Tillett Caroline
Chief Scientific Officer at Kenvue Inc.
- Company
- Kenvue Inc.
- Ticker
- KVUE
- First filing on record
- December 3, 2025
- Latest trade on record
- October 2, 2026
- SEC filings
- EDGAR ↗
Tillett Caroline, Chief Scientific Officer at Kenvue Inc., has disclosed 18 transactions in KVUE since December 3, 2025: 0 purchases (0 open-market buys) and 6 sales, worth about $884K at the reported prices. The latest was filed October 6, 2026, 4 days after the trade.
Open-market buys
0
Sales
6
Avg. disclosure lag
2.2d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Tillett Caroline made no purchases and 6 sales worth $459K, plus 12 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Tillett Caroline has traded 1 stock on record; the largest by dollars is KVUE.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 4 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 10 | 70,923 | — |
| F | Shares withheld for tax | 6 | 26,613 | $459K |
| A | Grant or award | 2 | 88,257 | $425K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 1 · $146K |
| 2025 | 15 | 0 | 5 · $313K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| KVUE | Sell F | October 2, 2026 | October 6, 2026 | 4d | 8,471 | $17 | $146K | Form 4 ↗ | ||
| KVUE | Other A | October 2, 2026 | October 6, 2026 | 4d | 24,732 | $17 | $425K | Form 4 ↗ | ||
| KVUE | Other A | March 2, 2026 | March 4, 2026 | 2d | 63,525 | — | — | derivative | Form 4 ↗ | |
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 3,372 | — | — | derivative | Form 4 ↗ | |
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 4,399 | — | — | derivative | Form 4 ↗ | |
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 2,994 | — | — | derivative | Form 4 ↗ | |
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 23,158 | — | — | derivative | Form 4 ↗ | |
| KVUE | Sell F | December 15, 2025 | December 17, 2025 | 2d | 1,725 | $17 | $30K | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 3,372 | — | — | Form 4 ↗ | ||
| KVUE | Sell F | December 15, 2025 | December 17, 2025 | 2d | 2,251 | $17 | $39K | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 4,399 | — | — | Form 4 ↗ | ||
| KVUE | Sell F | December 15, 2025 | December 17, 2025 | 2d | 1,532 | $17 | $26K | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 2,994 | — | — | Form 4 ↗ | ||
| KVUE | Sell F | December 15, 2025 | December 17, 2025 | 2d | 11,846 | $17 | $205K | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 15, 2025 | December 17, 2025 | 2d | 23,158 | — | — | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 1,539 | — | — | derivative | Form 4 ↗ | |
| KVUE | Sell F | December 1, 2025 | December 3, 2025 | 2d | 788 | $17 | $14K | Form 4 ↗ | ||
| KVUE | Option / conversion M | December 1, 2025 | December 3, 2025 | 2d | 1,539 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 6, 2026 | Form 4 | 0001944048-26-000155 | 2 | published | EDGAR ↗ |
| March 4, 2026 | Form 4 | 0001944048-26-000047 | 1 | published | EDGAR ↗ |
| December 17, 2025 | Form 4 | 0001944048-25-000226 | 12 | published | EDGAR ↗ |
| December 3, 2025 | Form 4 | 0001944048-25-000212 | 3 | published | EDGAR ↗ |
Other insiders at Kenvue Inc.
- Stevens Meredith Chief Operations Officer 33 rows
- Alvarado Luani Chief People Officer 28 rows
- Howlett Heather VP & Chief Accounting Officer 19 rows
- Orlando Matthew General Counsel 19 rows
- Healey Melanie Director 14 rows
- Lawson Carlton Group President EMEA & LA 12 rows
- Perry Kirk Chief Executive Officer 12 rows
- Smith Jeffrey C Director 8 rows
- ALLISON RICHARD E JR Director 7 rows
- Dyer Russell Chief Corp. Affairs Officer 7 rows
Everyone on file, with contracts and lobbying under the company's name: Kenvue Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 4 | 18 | December 3, 2025 | October 6, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.